SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $3.3 million in its first quarter.
The San Diego-based company said it had a loss of 31 cents per share.
The biopharmaceutical company posted revenue of $6.8 million in the period.
The company's shares closed at $1.25. A year ago, they were trading at $8.71.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS